110 related articles for article (PubMed ID: 17407708)
1. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study.
King JK; Yeh SH; Lin MW; Liu CJ; Lai MY; Kao JH; Chen DS; Chen PJ
Hepatology; 2002 Dec; 36(6):1416-24. PubMed ID: 12447867
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
[TBL] [Abstract][Full Text] [Related]
4. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
5. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between alpha-IFN anti-virus treatment and HLA-DRB1*11 gene mononucleotide polymorphism].
Chang JB; Zhou ZX; Xue R; Zhu GS; Tian YL; Zhao W
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):646-8. PubMed ID: 18822201
[TBL] [Abstract][Full Text] [Related]
8. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha.
Ma JC; Wang LW; Li XJ; Liao YF; Hu XY; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):166-71. PubMed ID: 17374576
[TBL] [Abstract][Full Text] [Related]
9. [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].
Li Z; Li HQ; Yan Y; Liu Y; Hao W; Niu JQ; Yin JM; Li H
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2105-8. PubMed ID: 17988528
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
11. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
12. Lack of interferon sensitivity-determining region in the genome of hepatitis B virus genotype Ba.
Liu CJ; Chen PJ; Lai MY; Chen TC; Wang HY; Huang WL; Kao JH; Chen DS
Antivir Ther; 2004 Dec; 9(6):895-903. PubMed ID: 15651748
[TBL] [Abstract][Full Text] [Related]
13. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
Saito T; Ito T; Ishiko H; Yonaha M; Morikawa K; Miyokawa A; Mitamura K
Am J Gastroenterol; 2003 Jun; 98(6):1377-83. PubMed ID: 12818284
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between HBV genotypes and the efficacy of antiviral therapies in hepatitis B e antigen- positive patients].
Zou HB; Zhu LM; Zhao GM; Liang SR; Li J; Lu CZ; Li H
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):425-7. PubMed ID: 17594806
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
19. Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.
Seo Y; Yoon S; Hamano K; Nakaji M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
Int J Mol Med; 2004 Jan; 13(1):75-9. PubMed ID: 14654974
[TBL] [Abstract][Full Text] [Related]
20. [MxA gene-88 G/T polymorphism influences the outcomes of HBV infection].
Yin SC; Peng XM; Gu L; Huang YS; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):418-21. PubMed ID: 16792864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
